Category

Michael J. Fox News Feed
At the current time, there is no identified biomarker for Parkinson’s disease (PD). In other words, there is no objective measure — no lab or imaging test, for example — that can tell whether a person has PD, what type of motor and non-motor symptoms will predominate and how those symptoms will change over time....
Read More
Parkinson’s disease (PD) is different for everyone and we don’t currently have any way of predicting what symptoms an individual with PD might experience or how they will progress. Identification of a biomarker — an objective measurement of Parkinson’s — could be used to diagnose and track the disease, and would greatly assist in clinical...
Read More
With two weeks remaining in April, there’s still plenty of time to make a difference this Parkinson’s Awareness Month. Team Fox continues to strive toward our $1 million goal — and you can help get us there. There are quick and simple ways that you can use your current Team Fox resources to engage your...
Read More
Today, MJFF announced the promotion of Sohini Chowdhury to Deputy Chief Executive Officer. In her previous role as Senior Vice President of Research Partnerships and throughout her twelve-year career at the Foundation, Ms. Chowdhury has been instrumental in driving the Foundation’s innovative alliances with key Parkinson’s stakeholders. As Deputy Chief Executive Officer, she will continue...
Read More
For the second year in a row, Magic Jigsaw Puzzles has partnered with Team Fox in honor of Parkinson’s Awareness Month. Throughout April, the gaming app — which lets you complete jigsaw puzzles from your mobile phone, tablet or desktop — will donate proceeds from purchases of specially marked Team Fox puzzle packs to the...
Read More
Over the past year or so, we’ve told you about a dyskinesia drug that is advancing toward U.S. Food and Drug Administration (FDA) approval. This week, Adamas Pharmaceuticals announced new data for this therapy, an extended-release formulation of amantadine designed to be taken once daily at bedtime. Results from two clinical trials demonstrated that individuals...
Read More
After a recent two week recess, members of Congress returned to the nation’s capital with several high-priority items on their agenda, including negotiations to keep the federal government open and renewed attempts to reform health care. Federal Government FundingThe government is currently funded through Friday, April 28. If the House and Senate can’t agree on...
Read More
On Tuesday April 25, the United States Senate formally declared April 2017 Parkinson’s Awareness Month, bringing attention to the disease and the needs of patients. The Senate resolution: (1) Continues to support research to find better treatments and a cure for Parkinson’s disease; (2) Recognizes the individuals living with Parkinson’s disease who participate in vital...
Read More
At The Michael J. Fox Foundation, we appreciate the opportunity to share the patient experience of Parkinson’s — and our urgent research agenda — with other stakeholders committed to speeding cures. Recently, Michael J. Fox and MJFF CEO Todd Sherer, PhD, addressed the hardware engineers, software engineers, computational biologists, clinicians, clinical researchers and basic scientists...
Read More
There is a lot of clinical and research data to suggest the gut is involved in Parkinson’s disease (PD). Constipation, a prominent non-motor symptom associated with PD, occurs years prior to diagnosis in many people. Alpha-synuclein, the sticky protein that clumps in the brains of those with PD, is present in the gut. And, research...
Read More
1 3 4 5